Brief: EMAValidates Nanexa's Clinical Trial Application For Of NEX-22

Nanexa AB

20/12/2023 07:07

Dec 20 (Reuters) - Nanexa AB  NANEXA.ST :
    * NANEXA’S CLINICAL TRIAL APPLICATION FOR NEX-22 PHASE I
STUDY
ASSESSED BY EMA
    * CLINICAL TRIAL APPLICATION FOR PHASE I STUDY OF NEX-22 IN
PATIENTS WITH TYPE 2 DIABETES HAS BEEN RECEIVED AND VALIDATED BY
EUROPEAN MEDICINES AGENCY (EMA)

Source text for Eikon:  ID:nMFN5mnYy6 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))